Malaysia's state-owned agri-business conglomerate FELDA is looking to tap growing demand for botanical drugs and treatments with a planned $300 million IPO (Initial Public Offering) of its life sciences unit on the Nasdaq exchange by March 2015, a press release confirmed.
Felda Wellness Corp (IPO-FWCP.O) is a unit of the Federal Land Development Authority of Malaysia (FELDA). The company had for long been thinking about going public and finally announced the listing today. It has chosen to list on the U.S. market for technology and biotech companies because of the country's well developed market for health products and U.S. investors' familiarity with such offerings, they said.
The only other Malaysian firm to have announced a Nasdaq listing is MOL Global Pte Ltd (IPO-MOLL.O), an online payment firm that also owns social networking site Friendster Inc. The company plans to raise $300 million from its U.S. IPO scheduled for this year end. Felda Wellness has been working with a New York-based investment bank with expertise in raising funds for life sciences companies in the United States. Bankers to advice on the deal will be chosen in September after the listing is approved by the FELDA board.
Top 5 Growth Companies For 2015: Bridgepoint Education Inc (BPI)
Bridgepoint Education, Inc. (Bridgepoint), incorporated in May 1999, is a provider of postsecondary education services. The Company�� academic institutions include Ashford University and University of the Rockies. Its institutions deliver programs primarily online, as well as at their traditional campuses. As of December 31, 2011, the Company had 86,642 total students enrolled in its institutions. Bridgepoint�� institutions conduct ongoing faculty and student assessment processes and provide a range of student services. The Company is also focused on developing new technologies, such as through Waypoint Outcomes, Constellation, and the development of its institutions' mobile learning platforms. The Company has developed Constellation to replace third party textbooks with digital course materials. Constellation materials are displayed in a browser-based platform. In January 2012, Bridgepoint introduced Thuze.
Ashford University offers associate's, bachelor's and master's degree programs online, as well as bachelor's degree programs at its campus in Clinton, Iowa. Ashford University consists of four colleges: the College of Business and Professional Studies, the College of Education, the College of Health, Human Services and Sciences, and the College of Liberal Arts. University of the Rockies is a graduate institution that offers master's and doctoral degree programs in the social and behavioral sciences. Classes at University of the Rockies are presented in a progressive online format, as well as at its campus in Colorado Springs, Colorado. Waypoint Outcomes provides learning and assessment software to K-12 and higher education institutions nationwide.
Constellation provides mobile access to students over the Internet, as well as on a variety of devices, including Web-enabled smartphones and tablet devices. Constellation is a cloud-based and is compatible across operating systems, browsers and mobile technologies. The Company has developed Constellation-enabled courses pri! marily in core classes to reach students. As of December 31, 2011, approximately 76% of Bridgepoint�� institutions' students had taken a Constellation-enabled course. As of December 31, 2011, it had 32 Constellation titles available. Thuze is a cloud-based, multi-platform, collaborative learning environment for students to interact with their course digital materials and with each other. Thuze provides students with the resources to work from both their desktop computers and also from their tablets and smartphones. It launched Thuze as a pilot program with publishers in higher education. During the year ended December 31, 2011, the Company deployed new mobile application technology at Ashford University. The Company has online students from all 50 states and from the District of Columbia. It has students from 69 different countries. As of December 31, 2011, over 34,400 students have graduated from the Company�� institutions, with approximately 15,200 students graduating from its institutions, during 2011.
Students finance their education at the Company's institutions through Title IV programs and Non-Title IV funding sources. Title IV programs includes The Federal Family Education Loan (FFEL) and Federal Direct Loan Programs. FFEL and Federal Direct Loan Programs consist of two loans: Stafford loans, which are either subsidized or unsubsidized, and PLUS loans, which are made available to graduate and professional students, as well as parents of dependent undergraduate students. Non-Title IV funding sources include other funding sources, which consist of cash, private loans, state grants, corporate reimbursement, military benefits and institutional loans. The Company has engaged Affiliated Computer Services, Inc. (ACS) to provide call center and transactional processing services for the online financial aid student populations at its institutions, including services related to disbursement eligibility review and Title IV fund returns. If Bridgepoint�� engagement with ACS were terminate! d, it wou! ld handle these processing services using its own resources or engage another third party vendor.
The Company�� institutions provide student support services, including academic, administrative and technology support. As of December 31, 2011, Bridgepoint�� institutions offered approximately 1,430 courses, 85 degree programs and 140 specializations. Its institutions offer programs and specialization areas through Ashford University's four colleges: the College of Business and Professional Studies; the College of Education; the College of Health, Human Services and Science; and the College of Liberal Arts, and through the University of the Rockies' two schools: the School of Organizational Leadership and the School of Professional Psychology. The Company�� leads are primarily generated from online sources. Its main source of leads is third party online lead aggregators. It also purchases keywords from search providers to generate online leads directly. In addition, the Company has an in-house team focused on generating online leads.
Advisors' Opinion:- [By Jake L'Ecuyer]
Bridgepoint Education (NYSE: BPI) shares tumbled 11.37 percent to $14.11 after the company announced a Q1 preliminary loss of $0.10 per share on sales of $160.5 million. The company also reported that it will be unable to file 10Q by May 12th.
- [By Jim Royal]
Earlier this week, Bridgepoint Education (NYSE: BPI ) revealed that the Western Association of Schools and Colleges had approved the company's Ashford University application for accreditation for five years. Investors had been concerned about this accreditation issue for the last year or so, and shares jumped on the news. They're now up about 50% from where my Special Situations portfolio bought in late April.
- [By Jim Royal]
One of my favorite reasons to reinvest in stocks I already own is when an uncertain, but favorable catalyst occurs, but the stock does little. So my Special Situations portfolio is adding $1,000 to each of the following three stocks: Cincinnati Bell (NYSE: CBB ) , Bridgepoint Education (NYSE: BPI ) , and First Financial Northwest (NASDAQ: FFNW ) . Read on to see why.
10 Best Life Sciences Stocks To Invest In Right Now: Celldex Therapeutics Inc(CLDX)
Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. The company markets Rotarix to treat rotavirus infection. Its lead drug candidate, rindopepimut (CDX-110), is an immunotherapeutic vaccine in Phase III clinical trial to target the tumor-specific molecule, epidermal growth factor receptor variant III, as well as in Phase II clinical trial for the indication of recurrent glioblastoma. The company?s other lead drug candidates comprise CDX-011, an antibody-drug conjugate in Phase IIb clinical trial for metastatic breast cancer and melanoma indication; and CDX-1127, a human monoclonal antibody in Phase I clinical trial for the treatment of lymphoma/leukemia and solid tumors. Its additional clinical and preclinical programs consist of CDX-1401, an Antigen Presenting Cells Targeting Technology program in Phase I/II clinical trial to tr eat multiple solid tumors; and CDX-301, an immune cell mobilizing agent and dendritic cell growth factor in Phase I clinical for treating cancer, autoimmune disease, and transplant. The company?s preclinical products include CDX-1135, a molecule for treating renal disease; and CDX-014, a human monoclonal antibody-drug conjugate for the treatment of ovarian and renal cancer. It has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; Duke University Brain Tumor Cancer Center; Ludwig Institute for Cancer Research; Alteris Therapeutics, Inc.; Thomas Jefferson University; 3M Company; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc. Celldex Therapeutics, Inc. was founded in 1983 and is headquartered in Needham, Massachusetts.
Advisors' Opinion:- [By John Udovich]
Biotech stocks and especially anything related to cancer has been a hot sector this year with plenty of good news with small cap cancer stocks like Clovis Oncology Inc (NASDAQ: CLVS), Celldex Therapeutics, Inc.(NASDAQ: CLDX) and MetaStat Inc (OTCBB: MTST). also recently reporting their share of good news. I should point out that one reason biotech or rather cancer is a hot area right now is because�big pharma companies who are loosing their�patent protection are looking for acquisitions with cancer in particular being a hot area. In addition and�thanks to a series of breakthroughs that have helped researchers understand the genetic basis of the disease, more investment or R&D dollars are flowing into cancer therapies or small cap biotechs in the cancer space.�With that in mind, here is the latest news about cancer or the cancer stocks or drug companies involved with finding new cancer treatments:
10 Best Life Sciences Stocks To Invest In Right Now: HSBC USA Inc (LSC)
HSBC USA Inc.( HSBC USA), incorporated on September 26, 1973, is a is an indirect wholly owned subsidiary of HSBC North America Holdings Inc. (HSBC North America), which is an indirect wholly owned subsidiary of HSBC Holdings plc (HSBC). HSBC USA�� principal business is to act as a holding company for its subsidiaries. The Company operates in four reportable segments: Retail Banking and Wealth Management (RBWM) (formerly Personal Financial Services), Commercial Banking (CMB), Global Banking and Markets and Private Banking (PB). In January 2011, the Company acquired Halbis Capital Management (USA) Inc (Halbis), an asset management business, from an affiliate, Halbis Capital Management (UK) Ltd. In April 2011, the Company completed the sale of its European Banknotes Business.
Through its subsidiaries, the Company offers a comprehensive range of personal and commercial banking products and related financial services. HSBC Bank USA, National Association (HSBC Bank USA), its principal United States (U.S) banking subsidiary, is a national banking association with banking branch offices and/or representative offices in 14 states and the District of Columbia. In addition to its domestic offices, the Company maintains foreign branch offices, subsidiaries and/or representative offices in the Caribbean, Europe, Asia, Latin America and Canada. Its customers include individuals, including net worth individuals, small businesses, corporations, institutions and governments. The Company also engages in mortgage banking and serve as an international dealer in derivative instruments denominated in U.S. dollars and other currencies, focusing on structuring of transactions to meet client�� needs.
Retail Banking and Wealth Management Segment
The Company Through its 461 branches (115 of which are in New York City), RBWM provides banking and wealth products and services, including personal loans, MasterCard and Visa credit card loans, deposits, branch services and financi! al planning products and services such as mutual funds, investments and insurance.
Commercial Banking Segment
The Company's Commercial banking Segment serves the growing number of united States companies that are increasingly in need of international banking and financial products and services as well as foreign companies in need of United States products and services. Commercial Banking offers comprehensive domestic and international services and banking, insurance and investment products to companies, government entities and non-profit organizations, with a particular emphasis on geographical collaboration to meet the banking needs of its international business customers. Commercial banking provides loan and deposit products, payments and cash management services, merchant services, trade and supply chain, corporate finance, global markets and risk advisory products and services to small businesses and middle-market corporations, including specialized products such as real estate financing. Commercial banking also offers various credit and trade related products such as standby facilities, performance guarantees and acceptances
Global Banking and Markets Segment
The Company�� Global Banking and Markets business segment supports HSBC�� emerging markets-led and financing-focused global strategy by leveraging HSBC Group advantages and scale, strength in developed and emerging markets and Global Markets products in order to focus on delivering international products to the United States clients and local products to international clients, with New York as the hub for the Americas business, including Canada and Latin America. Global Banking and Markets provides tailored financial solutions to government, corporate and institutional clients as well as private investors worldwide.Managed as a global business, Global Banking and Markets clients are served by sector-focused teams that bring together relationship managers and product specialists to dev! elop fina! ncial solutions that meet individual client needs.
Private Banking Segment
The Company�� private banking provides private banking and trustee services to high net worth individuals and families with local and international needs. Accessing the suitable products from the marketplace, private bank works with its clients to offer both traditional and new ways to manage and preserve wealth while optimizing returns. Private bank offers a range of wealth management and specialist advisory services, including banking, liquidity management, investment services, custody services, tailored lending, wealth planning, trust and fiduciary services, insurance, family wealth and philanthropy advisory services.
Advisors' Opinion:- [By DCResearch]
The opportunity exists because the once-thriving secondary/tertiary life settlement market has been all but abandoned by institutional investors, scared off by litigious insurers like Phoenix and a lack of manufactured policies. My research indicates that this undue pessimism towards life settlement contracts (LSC) has begun to reverse itself, or has at least stabilized. Investors who are far smarter than me are snapping up contracts and policies, seeking to capitalize on the uncorrelated, and excessive, IRRs. These investors seem to agree with our thesis that life settlements should outperform most other asset classes over a long enough time period.
10 Best Life Sciences Stocks To Invest In Right Now: Amira Nature Foods Ltd (ANFI)
Amira Nature Foods Ltd., incorporated on February 20, 2012, is a provider of packaged Indian specialty rice, with sales in over 40 countries. It generates the majority of its revenue through the sale of Basmati rice, a long-grain rice grown only in certain regions of the Indian sub-continent. The Company sells its products, primarily in emerging markets, through a distribution network. It sells its Amira brand in more than 25 countries. The Company sells its Amira branded products to Indian retailers such as Bharti Wal-Mart, Big Bazaar, Metro Cash & Carry, Spar, Spencer's Retail, Star Bazaar (Tesco in India) and Total and retailers, such as Carrefour, Costco, Jetro Restaurant Depot, Lulu's and Smart & Final, and through the foodservice channel. It participates across the entire rice supply chain from the procurement of paddy to its storage, aging, processing into rice, packaging, distribution and marketing. In June 2013, the Company announced that it has launched Amira branded products in the United Kingdom. In January 2014, Amira Nature Foods Ltd acquired Basmati Rice GmbH.
The Company operates an automated and integrated processing and milling facility that is located in the vicinity of the key Basmati rice paddy producing regions of northern India. The facility spans a covered area of 310,221 square feet, with a processing capacity of 24 metric tons of paddy per hour. During the year ended March 31, 2012, 34% of its revenue was derived from sales in India, and 50.3% was derived from sales in the Europe, Middle East and Africa region, or EMEA, 14.3% was derived from sales in the Asia Pacific region, and 1.4% was derived from sales in North America.
Advisors' Opinion:- [By Jeremy Bowman]
What:�Shares of�Amira Nature Foods� (NYSE: ANFI ) were looking healthier today, gaining as much as 11% after the company named a new chief financial officer last night.
- [By Roberto Pedone]
A consumer goods player that's starting to trend within range of triggering a big breakout trade is Amira Nature Foods (ANFI), a global provider of packaged Indian specialty rice, with sales in over 40 countries. This stock has been in play with the bulls over the last three months, with shares up 25%.
If you take a look at the chart for Amira Nature Foods, you'll notice that this stock has been uptrending strong for the last five months, with shares soaring higher from its low of $7.44 to its recent high of $17.41 a share. During that uptrend, shares of ANFI have been making mostly higher lows and higher highs, which is bullish technical price action. Shares of ANFI have started to break out above some key near-term overhead resistance levels today at $15.92 to $16.25 a share. That move is quickly pushing shares of ANFI within range of triggering another big breakout trade.
Traders should now look for long-biased trades in ANFI if it manages to break out above its all-time high of $17.41 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 226,387 shares. If that breakout triggers soon, then ANFI will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $25 to $27 a share.
Traders can look to buy ANFI off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $15.03 a share or around more key near-term support at $14.72 a share. One could also buy ANFI off strength once it starts to clear $17.41 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
10 Best Life Sciences Stocks To Invest In Right Now: Insys Therapeutics Inc (INSY)
Insys Therapeutics, Inc., incorporated on June 15, 1990, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company�� pharmaceuticals portfolio consists of one approved product and a number of product candidates targeting cancer-supportive care and cancer therapy. The Company�� product candidate includes Subsys, Dronabinol SG Capsule, Dronabinol RT Capsule, Dronabinol Oral Solution, Dronabinol Inhalation Device, and Dronabinol IV Solution. The Company is also developing cancer therapeutics, which is LEP-ETU, a formulation of paclitaxel, the active ingredient in the cancer drugs Taxol and Abraxane. On August 19, 2011, the Food & Drug Administration (FDA) approved its Dronabinol SG Capsule product, a generic equivalent to Marinol, for the treatment of chemotherapy induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS).
Subsys
The Company's Subsys is a single-use product that delivers fentanyl, an opioid analgesic, in seconds for transmucosal absorption underneath the tongue. Subsys is a transmucosal product to show pain relief when measuring the sum of pain intensity difference at five minutes in a Phase 3 breakthrough cancer pain (BTCP) clinical trial using fentanyl.
Dronabinol Product Family
The Company has an approved dronabinol product and is developing several dronabinol product candidates for the treatment of CINV and appetite stimulation in patients with AIDS, as well as other indications where dronabinol could have potential therapeutic benefits. Dronabinol, the active ingredient in Marinol, is a synthetic cannabinoid whose chemical name is delta-9-tetrahydrocannabinol (THC). Its portfolio consists of its Dronabinol SG Capsule product and Dronabinol RT Capsule product candidate, which are intended to be generic equi! valents to Marinol, in addition to three formulations, including Dronabinol Oral Solution. Dronabinol SG Capsule is a dronabinol soft gelatin capsule intended to be a generic equivalent to Marinol. Dronabinol RT Capsule is a dronabinol soft gel capsule that is stable at room temperature. Dronabinol Oral Solution is a ynthetic THC in an oral liquid formulation.
Cancer Therapeutics
In addition to its cancer-supportive care products, the Company intends to develop cancer therapeutics targeting limitations of existing commercial products. LEP-ETU, it advanced cancer therapeutic, is a NeoLipid liposomal, or microscopic membrane-like structure created from lipids, formulation that incorporates paclitaxel. LEP-ETU completed a Phase 2 clinical trial of 70 patients with metastatic breast cancer.
The Company competes with Cephalon, Inc., BioDelivery Sciences International, Inc., ProStrakan Group plc, Nycomed International Management GmbH, Archimedes Pharma Ltd., TEVA Pharmaceuticals USA, Watson Pharmaceuticals, Inc., AcelRx Pharmaceuticals, Inc., Akela Pharma Inc., Abbott Laboratories, Pharmaceutical International, Inc., Par Pharmaceutical Companies Inc., sanofi-aventis, Eisai Inc., Helsinn Group, Roche Holding AG, Par Pharmaceutical Companies Inc., GlaxoSmithKline plc, ProStrakan Group plc, Merck & Co, GW Pharmaceutical, A.P. Pharma, Inc., Aphios Corp., Roche Holding, Tesaro, Inc., Cornerstone Pharmaceutical, Inc., Bristol-Myers Squibb, Celgene Corporation, Laboratories, Amgen Inc., AstraZeneca PLC., Bayer AG, Biogen Idec Inc., Eisai Co., Ltd., F. Hoffmann- LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Onyx Pharmaceuticals Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.
Advisors' Opinion:- [By David Zeiler]
2. Insys Therapeutics Inc. (Nasdaq: INSY): Insys is a biotech seeking to capitalize on the growing interest in medical marijuana by using a generic form of THC to create drugs to treat cancer pain. INSY had its IPO May 2 with an offer price of $8 a share. The stock rose 19.75% on its first day of trading. But investors really warmed up to Insys later; it currently trades at about $37.54, a 369.25% increase over the offer price.
- [By Matt Jarzemsky]
Among companies that went public in the U.S. last year, FireEye has seen the second-biggest share rally since its IPO, trailing only pharmaceutical company Insys Therapeutics Inc.(INSY)
- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of INSYS Therapeutics (NASDAQ: INSY) were down 15.94 percent to $38.00 after the company received subpoena from Office of Inspector General. - [By Roberto Pedone]
One specialty pharmaceutical player that's quickly moving within range of triggering a big breakout trade is Insys Therapeutics (INSY), which develops and commercialize supportive care products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. This stock is off to a monster start in 2013, with shares up a whopping 434%.
>>5 Stocks Insiders Love Right Now
If you take a look at the chart for Insys Therapeutics, you'll notice that this stock has been uptrending strong for the last six months, with shares soaring higher from its low of $9.30 to its recent high of $53.64 a share. During that uptrend, shares of INSY have been making mostly higher lows and higher highs, which is bullish technical price action. Shares of INSY have recently pulled back to its 50-day moving average and the stock has now started to spike higher off that level. That spike is starting to push shares of INSY within range of triggering a big breakout trade.
Traders should now look for long-biased trades in INSY if it manages to break out above some near-term overhead resistance levels at $43.50 to $44.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 235,266 shares. If that breakout hits soon, then INSY will set up to re-test or possibly take out its next major overhead resistance levels at $47.25 to its all-time high at $53.64 a share.
Traders can look to buy INSY off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $38.75 a share or near its 50-day at $36.73 a share. One can also buy INSY off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
10 Best Life Sciences Stocks To Invest In Right Now: THERMOGENESIS Corp.(KOOL)
ThermoGenesis Corp. designs, develops, and sells medical products that enable the practice of regenerative medicine worldwide. It offers automated and semi-automated devices, and single-use processing disposables that enable the collection, processing, and cryopreservation of stem cells and other cellular tissues used in the practice of regenerative medicine. Regenerative medicine is a field that uses cell-based therapies to repair or restore lost or damaged tissue and cell function. The company?s products include the AXP System, a medical device that isolates and retrieves stem cells from umbilical cord blood; the BioArchive System, a robotic cryogenic medical device used by cord blood banks for the cryopreservation and archiving of cord blood stem cell units for transplant; the MarrowXpress or MXP System that isolates and concentrates stem cells from bone marrow; Res-Q 60 BMC, a point-of-care bone marrow stem cell processing system; and Res-Q 60 PRP, which is used for t he preparation of autologous platelet rich plasma from a sample of blood at the point of care. It also offers ThermoLine product line, which includes ultra-rapid plasma ThermoLine Freezer and ultra-rapid plasma ThermoLine Thawer; and CryoSeal System, an automated system, which is used to prepare an autologous hemostatic surgical sealant. ThermoGenesis Corp. was founded in 1986 and is based in Rancho Cordova, California.
Advisors' Opinion:- [By John Udovich]
The controversy over stem cell research or their usage seems to have ebbed in recent years as stem cell science moves beyond the use of embryos and lately there has been a steady flow of overlooked good news from the sector or from small cap stem cell stocks like Cellular Dynamics (which will IPO soon), ThermoGenesis Corp (NASDAQ: KOOL) and BioRestorative Therapies (OTCBB: BRTX) for investors to digest. Just consider the following news:
- [By Monica Gerson]
ThermoGenesis (NASDAQ: KOOL) moved up 29.81% to $2.9857. ThermoGenesis' trailing-twelve-month revenue is $17.49 million.
Infosonics (NASDAQ: IFON) shares jumped 22.64% to $2.06. Infosonics shares have jumped 170.97% over the past 52 weeks, while the S&P 500 index has gained 23.35% in the same period.
10 Best Life Sciences Stocks To Invest In Right Now: Ametek Inc (AME)
AMETEK, Inc. (AMETEK), incorporated in 1930, is a global manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America. The Company markets its products worldwide through two groups: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). EIG builds monitoring, testing, calibration and display devices for the process, aerospace, industrial, power and medical markets. EMG produces engineered electromechanical connectors for hermetic (moisture-proof) applications, specialty metals for niche markets and brushless air-moving motors, blowers and heat exchangers. End markets include aerospace, defense, mass transit, medical, office products and other industrial markets. In December 2013, the Company announced that it has acquired Powervar, a provider of power management systems and uninterruptible power supply (UPS) systems. In January 2014, the Company acquired Teseq Group. In February 2014, the Company acquired VTI Instruments.
The Electronic Instruments Group
EIG consists of a group of differentiated businesses. EIG manufactures instruments used for testing, monitoring, calibration and display for the process, aerospace, industrial and power markets. EIG is specialized in the markets it serves, including aerospace engine sensors, heavy-vehicle instrument panels, analytical instrumentation, level measurement products, power instruments and pressure gauges. It has joint venture operations in China, Taiwan and Japan. EIG had 56 operating facilities: 35 in the United States, seven in the United Kingdom, five in Germany, three in France, two in Switzerland and one each in Argentina, Austria, Canada and Denmark, as of December 31, 2011. EIG also shares operating facilities with EMG in China and Mexico.
Process and analytical measurement and analysis instruments include oxygen, moisture, combustion and liquid analyzers; emission monitors; spectrometers; mechanical and electronic ! pressure sensors and transmitters; radiation measurement devices; level measurement devices; precision pumping systems, and force-measurement and materials testing instrumentation. EIG�� focus is on the process industries, including oil, gas and petrochemical refining, power generation, specialty gas production, water and waste treatment, natural gas distribution and semiconductor manufacturing. AMETEK�� analytical instruments are also used for precision measurement in a number of other applications including radiation detection for the United States Department of Homeland Security, materials analysis, nanotechnology research and other test and measurement applications.
TMC serves the manufacturers of life sciences, photonics and semiconductor equipment with a range of custom active piezoelectric vibration cancellation systems, based on their patented active piezo technology. TMC also supplies passive vibration cancellation systems, optical test tables, acoustic isolation hoods and magnetic isolation hoods. Reichert Technologies provides high-technology instruments used by ophthalmologists, optometrists, and opticians for vision correction and the screening and diagnosis of eye diseases, such as glaucoma and macular degeneration.
Atlas Material Testing Technology LLC (Atlas) has products, which include weather exposure test systems, corrosion-testing instruments, specialty lighting systems, and large-scale weathering test chambers. In addition, Atlas offers indoor laboratory and outdoor testing services, photovoltaic and solar testing and consulting. AMETEK�� power businesses provide analytical instruments, uninterruptible power supply systems and programmable power supplies used in a range of industrial settings. EIG designs and manufactures power measurement and recording instrumentation used by the electric power and manufacturing industries. Those products include power transducers and meters, event and transient recorders, annunciators and alarm monitoring systems us! ed to mea! sure, monitor and record variables in the transmission and distribution of electric power.
EIG�� Solidstate Controls business designs and manufactures uninterruptible power supply systems for the process and power generation industries. EIG also manufactures sensor systems for land-based gas turbines and for boilers and burners used by the utility, petrochemical, process and marine industries worldwide. EIG�� programmable power business provides programmable alternating current (AC) and direct current (DC) power sources. EM Test provides equipment used to perform electrical immunity and electromagnetic compatibility testing. EM Test manufactures a full line of conducted electromagnetic compatibility test equipment, including electrical fast transient generators, electrostatic discharge simulators, surge generators, waveform simulators and multifunctional generators.
Aerospace products include airborne data systems; turbine engine temperature measurement products; vibration-monitoring systems; indicators; displays; fuel and fluid measurement products; sensors; switches; cable harnesses, and transducers. EIG serves all segments of commercial aerospace, including helicopters, business jets, commuter aircraft and commercial airliners, as well as the military market. Its customers are the producers of airframes and jet engines and other aerospace system integrators. The Company also serves the commercial aerospace aftermarket with spare part sales and repair and overhaul services.
Electromechanical Group
EMG provides engineered motors, blowers, fans, heat exchangers, connectors, and other electromechanical products or systems for commercial and military aerospace applications, defense, medical equipment, business machines, computers and other power or industrial applications. EMG had 58 operating facilities: 34 in the United States, nine in the United Kingdom, three in France, two each in China, Czech Republic, Italy and Mexico and one each in Brazil, M! alaysia, ! Morocco and Taiwan, as of December 31, 2011. Differentiated businesses consists of the technical motors and systems businesses and the engineered materials, interconnects and packaging businesses. Technical motors and systems consist of brushless motors, blowers and pumps, as well as other electromechanical systems. These products are used in aerospace and defense, business machines, computer equipment, mass transit vehicles, medical equipment, power, and industrial applications.
EMG produces electronically commutated (brushless) motors, blowers and pumps. These motor-blower systems and heat exchangers are used for thermal management and other applications on a range of military and commercial aircraft and military ground vehicles, and are used in medical and other applications. These motors provide cooling and ventilation for business machines, computers and mass transit vehicles. EMG also serves the commercial and military aerospace third-party maintenance, repair and overhaul (MRO) market. These services are provided on a global basis with facilities in the United States, Europe and Singapore.
During the year ended December 31, 2011, engineered materials, interconnects and packaging products represented 37% of EMG�� net sales. AMETEK provides specialized metal powder, strip, wire and bonded products. It produces stainless steel and nickel clad alloys; stainless steel, cobalt and nickel alloy powders; metal strip; specialty shaped and electronic wire, and advanced metal matrix composites used in electronic thermal management. Its products are used in automotive, appliance, medical and surgical, aerospace, telecommunications, marine and general industrial applications.
Coining provides custom-shaped preforms, microstampings and wire used for joining electronic circuitry, packaging microelectronics and providing thermal protection and electric conductivity for a range of electronic devices. Coining�� products are used in engineered applications for the radio f! requency ! (RF)/microwave, photonics, medical, aerospace and defense, and general electronics industries. Avicenna produces fine-featured catheter and other medical components for leads, guide wires and custom medical assemblies. Avicenna complements the Company�� medical device market businesses fits with its Technical Services for Electronics (TSE) business. TSE fits with the HCC Industries division, which manufactures engineered electronic interconnects and microelectronics packaging for sophisticated electronic applications.
AMETEK is a medical interconnects provider with integrated capabilities for the catheter, cardiac and neurostimulation markets. During 2011, floorcare and specialty motor markets represented 18% of EMG�� net sales, where it sells air-moving electric motors to the floorcare other equipment manufacturers (OEMs), including vertically integrated OEMs that produce some of their own motors. EMG produces motor-blowers for a range of floorcare products, ranging from hand-held, canister and upright vacuums to central vacuums for residential use. High-performance vacuum motors also are marketed for commercial and industrial applications.
The Company also manufactures a variety of specialty motors used in a range of products, such as household and personal care appliances; fitness equipment; electric materials handling vehicles, and sewing machines. In addition, its products are used in outdoor power equipment, such as electric chain saws, leaf blowers, string trimmers and power washers.
Advisors' Opinion:- [By Gregory Vousvounis]
Ametek (AME) is a global manufacturer of electronic instruments and electromechanical devices. Ametek is a strong leader in most of its niche markets having either a low-cost advantage over competitors or higher-quality products that address critical customer needs.
- [By John Udovich]
In addition to recent news, there are a couple of upcoming events that is bound to gain Advanced Micro Devices, Inc (NYSE: AMD) some attention from investors and traders alike. I should note that Advanced Micro Devices is in our�SmallCap Network Elite Opportunity (SCN EO) portfolio as we believe its making progress in the transition away from the PC market, but�the performance of our position has been rather up and down recently (currently we are down about 2%). Nevertheless, there is still enough good news to keep us excited about the stock�� future performance. Just consider the following recent news:
Upcoming AMD GPU ��4 Tech Day. On Wednesday, Advanced Micro Devices will unveil its next-generation graphics processing unit at the AMD GPU ��4 Tech Day event. Its not known whether�the company plans to unleash an all-new product family for 2014 or just�a flagship GPU due to arrive in Q4 2013. There will be�a real-time video webcast of the showcase available on the�Investor Relations home page here. Micro Server Pioneer Andrew Feldman is Interviewed. VentureBeat has interviewed Andrew Feldman who is one of the pioneers of micro servers after his�company, SeaMicro, used low-cost Intel Atom chips to create a category of servers with lots of processors in a single machine�and exceptionally low power consumption. Advanced Micro Devices bought SeaMicro early last year for $334 million in order to gain entry into the energy-efficient server market as well as�gain new insights into server customers. Feldman is now corporate vice president and general manager of AMD�� server group and the interview will give investors some insight into the company�� server business. Sony Expects to Sell 5 Million PlayStation 4s for the Holidays and Into the New Year. Bloomberg has recently reported that Sony Corp. expects the PlayStation 4�� lower price and wider variety of entertainment services to drive its forecast to sell 5 million units by the end of March.� - [By Rich Smith]
The U.S. Department of Defense announced a half dozen new contracts benefiting the U.S. Navy Wednesday. Of these, five went to publicly traded companies, namely:
- [By Rich Duprey]
Electronic device maker�Ametek� (NYSE: AME ) �announced today�its second-quarter dividend of $0.06 per share, the same rate it paid for the last five quarters after it raised the payout 50% from $0.04 per share.
No comments:
Post a Comment